ARTICLE | Company News
Gilead, Lupin cardiovascular news
August 19, 2013 7:00 AM UTC
Gilead granted Lupin rights to launch a generic version of Gilead's angina drug Ranexa ranolazine on Feb. 27, 2019. The deal is part of a settlement of a 2010 suit Gilead filed in the U.S. District C...